Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
168 hedge funds and large institutions have $300M invested in Meridian Bioscience Inc in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 52 increasing their positions, 58 reducing their positions, and 31 closing their positions.
10% more call options, than puts
Call options by funds: $502K | Put options by funds: $458K
3% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 31
1% less funds holding
Funds holding: 170 → 168 (-2)
10% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 58
17% less capital invested
Capital invested by funds: $363M → $300M (-$62M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.46M |
| 2 |
JP Morgan Chase
New York
|
+$3.54M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.51M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$2.06M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.01M |
| 2 |
BlackRock
New York
|
-$2.83M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.73M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2.71M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.54M |
VIVO Hedge Fund Activity: Q1 2020 in Review
168 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2020, worth a combined $300M — down 17% from $363M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of VIVO and 30 opened new positions — a net loss of 1 holder — while 58 trimmed existing stakes and 52 added.
The largest buyer was Millennium Management, adding an estimated $8.46M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $5.01M sold.
- 168 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2020, down from 170 in Q4 2019.
- Funds reported $300M of Meridian Bioscience Inc stock for Q1 2020, down 17% quarter-over-quarter.
- 30 funds opened new Meridian Bioscience Inc positions in Q1 2020 and 31 closed out, a net change of -1 holder.
- The largest Meridian Bioscience Inc buyer in Q1 2020 was Millennium Management, an estimated $8.46M added.
- The largest Meridian Bioscience Inc seller in Q1 2020 was Point72 Asset Management, an estimated $5.01M sold.
Based on aggregated 13F filings for Q1 2020.